Adjuvant whole-brain radiotherapy versus observation after radiosurgery or surgical resection of one to three cerebral metastases: results of the EORTC 22952-26001 study

This European Organisation for Research and Treatment of Cancer phase III trial assesses whether adjuvant whole-brain radiotherapy (WBRT) increases the duration of functional independence after surgery or radiosurgery of brain metastases. Patients with one to three brain metastases of solid tumors (...

Celý popis

Uložené v:

Podrobná bibliografia
Vydané v:	Journal of clinical oncology Ročník 29; číslo 2; s. 134
Hlavní autori:	Kocher, Martin, Soffietti, Riccardo, Abacioglu, Ufuk, Villà, Salvador, Fauchon, Francois, Baumert, Brigitta G, Fariselli, Laura, Tzuk-Shina, Tzahala, Kortmann, Rolf-Dieter, Carrie, Christian, Ben Hassel, Mohamed, Kouri, Mauri, Valeinis, Egils, van den Berge, Dirk, Collette, Sandra, Collette, Laurence, Mueller, Rolf-Peter
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	United States 10.01.2011
Predmet:	Adult Aged Aged, 80 and over Brain Neoplasms - radiotherapy Brain Neoplasms - secondary Brain Neoplasms - surgery Brain Neoplasms - therapy Disease Progression Disease-Free Survival Female Humans Male Middle Aged Radiosurgery - adverse effects Radiotherapy - adverse effects Radiotherapy, Adjuvant Salvage Therapy Survival Rate
ISSN:	1527-7755, 1527-7755
On-line prístup:	Zistit podrobnosti o prístupe
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!

Abstract	This European Organisation for Research and Treatment of Cancer phase III trial assesses whether adjuvant whole-brain radiotherapy (WBRT) increases the duration of functional independence after surgery or radiosurgery of brain metastases. Patients with one to three brain metastases of solid tumors (small-cell lung cancer excluded) with stable systemic disease or asymptomatic primary tumors and WHO performance status (PS) of 0 to 2 were treated with complete surgery or radiosurgery and randomly assigned to adjuvant WBRT (30 Gy in 10 fractions) or observation (OBS). The primary end point was time to WHO PS deterioration to more than 2. Of 359 patients, 199 underwent radiosurgery, and 160 underwent surgery. In the radiosurgery group, 100 patients were allocated to OBS, and 99 were allocated to WBRT. After surgery, 79 patients were allocated to OBS, and 81 were allocated to adjuvant WBRT. The median time to WHO PS more than 2 was 10.0 months (95% CI, 8.1 to 11.7 months) after OBS and 9.5 months (95% CI, 7.8 to 11.9 months) after WBRT (P = .71). Overall survival was similar in the WBRT and OBS arms (median, 10.9 v 10.7 months, respectively; P = .89). WBRT reduced the 2-year relapse rate both at initial sites (surgery: 59% to 27%, P < .001; radiosurgery: 31% to 19%, P = .040) and at new sites (surgery: 42% to 23%, P = .008; radiosurgery: 48% to 33%, P = .023). Salvage therapies were used more frequently after OBS than after WBRT. Intracranial progression caused death in 78 (44%) of 179 patients in the OBS arm and in 50 (28%) of 180 patients in the WBRT arm. After radiosurgery or surgery of a limited number of brain metastases, adjuvant WBRT reduces intracranial relapses and neurologic deaths but fails to improve the duration of functional independence and overall survival.
AbstractList	This European Organisation for Research and Treatment of Cancer phase III trial assesses whether adjuvant whole-brain radiotherapy (WBRT) increases the duration of functional independence after surgery or radiosurgery of brain metastases. Patients with one to three brain metastases of solid tumors (small-cell lung cancer excluded) with stable systemic disease or asymptomatic primary tumors and WHO performance status (PS) of 0 to 2 were treated with complete surgery or radiosurgery and randomly assigned to adjuvant WBRT (30 Gy in 10 fractions) or observation (OBS). The primary end point was time to WHO PS deterioration to more than 2. Of 359 patients, 199 underwent radiosurgery, and 160 underwent surgery. In the radiosurgery group, 100 patients were allocated to OBS, and 99 were allocated to WBRT. After surgery, 79 patients were allocated to OBS, and 81 were allocated to adjuvant WBRT. The median time to WHO PS more than 2 was 10.0 months (95% CI, 8.1 to 11.7 months) after OBS and 9.5 months (95% CI, 7.8 to 11.9 months) after WBRT (P = .71). Overall survival was similar in the WBRT and OBS arms (median, 10.9 v 10.7 months, respectively; P = .89). WBRT reduced the 2-year relapse rate both at initial sites (surgery: 59% to 27%, P < .001; radiosurgery: 31% to 19%, P = .040) and at new sites (surgery: 42% to 23%, P = .008; radiosurgery: 48% to 33%, P = .023). Salvage therapies were used more frequently after OBS than after WBRT. Intracranial progression caused death in 78 (44%) of 179 patients in the OBS arm and in 50 (28%) of 180 patients in the WBRT arm. After radiosurgery or surgery of a limited number of brain metastases, adjuvant WBRT reduces intracranial relapses and neurologic deaths but fails to improve the duration of functional independence and overall survival. This European Organisation for Research and Treatment of Cancer phase III trial assesses whether adjuvant whole-brain radiotherapy (WBRT) increases the duration of functional independence after surgery or radiosurgery of brain metastases.PURPOSEThis European Organisation for Research and Treatment of Cancer phase III trial assesses whether adjuvant whole-brain radiotherapy (WBRT) increases the duration of functional independence after surgery or radiosurgery of brain metastases.Patients with one to three brain metastases of solid tumors (small-cell lung cancer excluded) with stable systemic disease or asymptomatic primary tumors and WHO performance status (PS) of 0 to 2 were treated with complete surgery or radiosurgery and randomly assigned to adjuvant WBRT (30 Gy in 10 fractions) or observation (OBS). The primary end point was time to WHO PS deterioration to more than 2.PATIENTS AND METHODSPatients with one to three brain metastases of solid tumors (small-cell lung cancer excluded) with stable systemic disease or asymptomatic primary tumors and WHO performance status (PS) of 0 to 2 were treated with complete surgery or radiosurgery and randomly assigned to adjuvant WBRT (30 Gy in 10 fractions) or observation (OBS). The primary end point was time to WHO PS deterioration to more than 2.Of 359 patients, 199 underwent radiosurgery, and 160 underwent surgery. In the radiosurgery group, 100 patients were allocated to OBS, and 99 were allocated to WBRT. After surgery, 79 patients were allocated to OBS, and 81 were allocated to adjuvant WBRT. The median time to WHO PS more than 2 was 10.0 months (95% CI, 8.1 to 11.7 months) after OBS and 9.5 months (95% CI, 7.8 to 11.9 months) after WBRT (P = .71). Overall survival was similar in the WBRT and OBS arms (median, 10.9 v 10.7 months, respectively; P = .89). WBRT reduced the 2-year relapse rate both at initial sites (surgery: 59% to 27%, P < .001; radiosurgery: 31% to 19%, P = .040) and at new sites (surgery: 42% to 23%, P = .008; radiosurgery: 48% to 33%, P = .023). Salvage therapies were used more frequently after OBS than after WBRT. Intracranial progression caused death in 78 (44%) of 179 patients in the OBS arm and in 50 (28%) of 180 patients in the WBRT arm.RESULTSOf 359 patients, 199 underwent radiosurgery, and 160 underwent surgery. In the radiosurgery group, 100 patients were allocated to OBS, and 99 were allocated to WBRT. After surgery, 79 patients were allocated to OBS, and 81 were allocated to adjuvant WBRT. The median time to WHO PS more than 2 was 10.0 months (95% CI, 8.1 to 11.7 months) after OBS and 9.5 months (95% CI, 7.8 to 11.9 months) after WBRT (P = .71). Overall survival was similar in the WBRT and OBS arms (median, 10.9 v 10.7 months, respectively; P = .89). WBRT reduced the 2-year relapse rate both at initial sites (surgery: 59% to 27%, P < .001; radiosurgery: 31% to 19%, P = .040) and at new sites (surgery: 42% to 23%, P = .008; radiosurgery: 48% to 33%, P = .023). Salvage therapies were used more frequently after OBS than after WBRT. Intracranial progression caused death in 78 (44%) of 179 patients in the OBS arm and in 50 (28%) of 180 patients in the WBRT arm.After radiosurgery or surgery of a limited number of brain metastases, adjuvant WBRT reduces intracranial relapses and neurologic deaths but fails to improve the duration of functional independence and overall survival.CONCLUSIONAfter radiosurgery or surgery of a limited number of brain metastases, adjuvant WBRT reduces intracranial relapses and neurologic deaths but fails to improve the duration of functional independence and overall survival.
Author	Kocher, Martin Tzuk-Shina, Tzahala Mueller, Rolf-Peter Ben Hassel, Mohamed Kortmann, Rolf-Dieter Carrie, Christian Kouri, Mauri Fauchon, Francois Collette, Laurence Abacioglu, Ufuk Fariselli, Laura Soffietti, Riccardo Villà, Salvador Valeinis, Egils Collette, Sandra Baumert, Brigitta G van den Berge, Dirk
Author_xml	– sequence: 1 givenname: Martin surname: Kocher fullname: Kocher, Martin email: martin.kocher@uk-koeln.de organization: University of Cologne, Cologne, Germany. martin.kocher@uk-koeln.de – sequence: 2 givenname: Riccardo surname: Soffietti fullname: Soffietti, Riccardo – sequence: 3 givenname: Ufuk surname: Abacioglu fullname: Abacioglu, Ufuk – sequence: 4 givenname: Salvador surname: Villà fullname: Villà, Salvador – sequence: 5 givenname: Francois surname: Fauchon fullname: Fauchon, Francois – sequence: 6 givenname: Brigitta G surname: Baumert fullname: Baumert, Brigitta G – sequence: 7 givenname: Laura surname: Fariselli fullname: Fariselli, Laura – sequence: 8 givenname: Tzahala surname: Tzuk-Shina fullname: Tzuk-Shina, Tzahala – sequence: 9 givenname: Rolf-Dieter surname: Kortmann fullname: Kortmann, Rolf-Dieter – sequence: 10 givenname: Christian surname: Carrie fullname: Carrie, Christian – sequence: 11 givenname: Mohamed surname: Ben Hassel fullname: Ben Hassel, Mohamed – sequence: 12 givenname: Mauri surname: Kouri fullname: Kouri, Mauri – sequence: 13 givenname: Egils surname: Valeinis fullname: Valeinis, Egils – sequence: 14 givenname: Dirk surname: van den Berge fullname: van den Berge, Dirk – sequence: 15 givenname: Sandra surname: Collette fullname: Collette, Sandra – sequence: 16 givenname: Laurence surname: Collette fullname: Collette, Laurence – sequence: 17 givenname: Rolf-Peter surname: Mueller fullname: Mueller, Rolf-Peter
BackLink	https://www.ncbi.nlm.nih.gov/pubmed/21041710$$D View this record in MEDLINE/PubMed
BookMark	eNpNkF9LwzAUxYNM3Ka--yR586kzSZs29W2U-Y_BQOZzSdNb19E2M0kn_Uh-SzM3Qbhwz738uOdwp2jU6Q4QuqFkRhkh96_ZasaIn0K_iDk_QxPKWRIkCeejf3qMptZuCaGRCPkFGjNKIppQMkHf83Lb72Xn8NdGNxAURtYdNrKstduAkbsB78HY3mJdWDB76WrdYVk5MEfK9uYDzIC1wQdZK9lgAxbUL6gr7BNjp7HbGACswIC3aHALTlpfYB8OeN84e4C9J16s3tYZZizlLGCxD42t68vhCp1XsrFwfeqX6P1xsc6eg-Xq6SWbLwPFGXVBCCIpokQKUpEyKaiKJY9EWfGCQZnEImZUSVIKXsQpFBDFlUoZFTJSMiURYewS3R3v7oz-7MG6vK2tgqaRHeje5sInI2EoiCdvT2RftFDmO1O30gz533fZD4_5gEo
CitedBy_id	crossref_primary_10_1016_j_prro_2017_04_011 crossref_primary_10_3390_cancers14061514 crossref_primary_10_1007_s11060_017_2652_0 crossref_primary_10_3390_cancers14061515 crossref_primary_10_1016_j_prro_2017_04_016 crossref_primary_10_1016_j_wneu_2018_05_120 crossref_primary_10_1200_JCO_19_01414 crossref_primary_10_1016_j_wnsx_2025_100432 crossref_primary_10_3390_cancers11030294 crossref_primary_10_1093_neuonc_noz105 crossref_primary_10_3171_2022_3_JNS212301 crossref_primary_10_1245_s10434_011_2019_2 crossref_primary_10_3389_fonc_2015_00027 crossref_primary_10_1016_j_ijrobp_2016_03_013 crossref_primary_10_1186_s40880_019_0416_2 crossref_primary_10_1155_2019_1568465 crossref_primary_10_1590_1806_9282_62_05_389 crossref_primary_10_1007_s13566_013_0116_5 crossref_primary_10_1067_j_cpsurg_2018_08_004 crossref_primary_10_3389_fonc_2024_1411432 crossref_primary_10_1016_j_ijrobp_2019_02_051 crossref_primary_10_1007_s13246_023_01241_8 crossref_primary_10_1016_j_athoracsur_2018_10_029 crossref_primary_10_1186_s12885_020_07491_z crossref_primary_10_1016_j_ctro_2022_09_005 crossref_primary_10_1002_cncr_33459 crossref_primary_10_1016_j_cllc_2014_04_008 crossref_primary_10_1016_j_jocn_2014_07_019 crossref_primary_10_1007_s00066_014_0808_9 crossref_primary_10_1007_s11060_019_03383_w crossref_primary_10_1093_neuonc_nox150 crossref_primary_10_1136_jitc_2021_003730 crossref_primary_10_1007_s11060_023_04380_w crossref_primary_10_1016_j_neurol_2023_03_005 crossref_primary_10_3390_cancers15072047 crossref_primary_10_1002_cam4_206 crossref_primary_10_1038_s41598_019_53456_z crossref_primary_10_1186_s12885_019_6431_5 crossref_primary_10_1089_jpm_2014_9417 crossref_primary_10_1007_s11060_023_04293_8 crossref_primary_10_1007_s00761_018_0485_x crossref_primary_10_3389_fneur_2023_1344672 crossref_primary_10_3390_cancers3044010 crossref_primary_10_1016_j_radonc_2020_11_021 crossref_primary_10_3171_2014_7_GKS141488 crossref_primary_10_1186_s13014_019_1252_x crossref_primary_10_1200_JCO_2013_49_4443 crossref_primary_10_1016_j_radonc_2014_12_011 crossref_primary_10_3389_fonc_2021_719936 crossref_primary_10_1007_s00761_014_2741_z crossref_primary_10_1097_COC_0000000000000868 crossref_primary_10_1007_s12672_024_01176_w crossref_primary_10_1089_thy_2020_0947 crossref_primary_10_1212_01_CON_0000464178_81957_18 crossref_primary_10_1016_j_jtocrr_2023_100553 crossref_primary_10_1016_j_mri_2019_09_011 crossref_primary_10_1007_s11940_021_00664_6 crossref_primary_10_1016_j_cllc_2023_01_002 crossref_primary_10_1007_s11864_024_01286_1 crossref_primary_10_1093_bjr_tqae051 crossref_primary_10_1111_ans_15040 crossref_primary_10_1016_j_clineuro_2011_10_013 crossref_primary_10_1177_1533034614568097 crossref_primary_10_1227_NEU_0b013e31827b99f3 crossref_primary_10_1186_s40001_023_01178_4 crossref_primary_10_1007_s00066_018_1368_1 crossref_primary_10_1016_j_prro_2020_04_009 crossref_primary_10_3171_2013_7_JNS13431 crossref_primary_10_1016_j_ijrobp_2018_06_021 crossref_primary_10_1016_j_lungcan_2014_06_001 crossref_primary_10_1007_s11060_015_1915_x crossref_primary_10_1007_s11060_015_1937_4 crossref_primary_10_1097_PPO_0b013e31824b2890 crossref_primary_10_3389_fonc_2020_572644 crossref_primary_10_3390_biology12040585 crossref_primary_10_1007_s11910_018_0877_8 crossref_primary_10_1200_JCO_2018_78_6186 crossref_primary_10_1016_j_ijrobp_2013_12_013 crossref_primary_10_3892_ol_2017_6359 crossref_primary_10_3389_fendo_2021_730025 crossref_primary_10_1186_s12885_022_10083_8 crossref_primary_10_1007_s11060_023_04325_3 crossref_primary_10_1007_s10549_014_3242_x crossref_primary_10_1093_neuonc_noz147 crossref_primary_10_1016_j_ijrobp_2019_03_052 crossref_primary_10_1016_j_wneu_2018_06_138 crossref_primary_10_1586_14737175_2013_853445 crossref_primary_10_1586_era_11_165 crossref_primary_10_1016_j_ctro_2024_100893 crossref_primary_10_3171_2016_7_GKS161499 crossref_primary_10_3892_mco_2019_1830 crossref_primary_10_3171_2014_12_JNS141919 crossref_primary_10_1177_1756286418785502 crossref_primary_10_1007_s11060_015_1881_3 crossref_primary_10_3389_fonc_2024_1339126 crossref_primary_10_1007_s13566_015_0242_3 crossref_primary_10_1007_s00066_011_0024_9 crossref_primary_10_1007_s11548_021_02412_2 crossref_primary_10_1007_s00066_024_02239_1 crossref_primary_10_1007_s15015_020_2515_y crossref_primary_10_1016_j_lana_2023_100584 crossref_primary_10_1016_S1470_2045_15_00141_2 crossref_primary_10_1093_neuonc_noac106 crossref_primary_10_1007_s11060_021_03938_w crossref_primary_10_3390_cancers13030380 crossref_primary_10_3390_brainsci12070879 crossref_primary_10_1007_s00066_021_01831_z crossref_primary_10_1186_s13014_017_0840_x crossref_primary_10_1200_JCO_2011_41_0639 crossref_primary_10_1007_s12609_024_00558_x crossref_primary_10_1016_j_radonc_2022_05_029 crossref_primary_10_1200_JCO_25_00056 crossref_primary_10_1097_MD_0000000000011777 crossref_primary_10_1007_s10549_017_4107_x crossref_primary_10_1016_j_ejca_2012_05_016 crossref_primary_10_1016_S1470_2045_17_30692_7 crossref_primary_10_1227_neu_0000000000002491 crossref_primary_10_2147_CMAR_S476837 crossref_primary_10_1007_s11060_016_2128_7 crossref_primary_10_2217_fon_2020_0094 crossref_primary_10_3390_cancers13051078 crossref_primary_10_1093_annonc_mdx332 crossref_primary_10_1371_journal_pone_0195608 crossref_primary_10_4103_ijc_IJC_786_18 crossref_primary_10_1053_j_seminoncol_2015_02_006 crossref_primary_10_1007_s00701_012_1606_8 crossref_primary_10_1016_j_lungcan_2022_06_017 crossref_primary_10_1088_1742_6596_777_1_012031 crossref_primary_10_1186_s13014_015_0562_x crossref_primary_10_1002_acm2_14459 crossref_primary_10_1002_acm2_14218 crossref_primary_10_3390_medicina60091464 crossref_primary_10_1002_acm2_13130 crossref_primary_10_1016_j_wneu_2022_09_079 crossref_primary_10_1200_JCO_2013_48_9286 crossref_primary_10_1007_s13566_012_0046_7 crossref_primary_10_1080_14737140_2017_1358090 crossref_primary_10_1007_s11060_022_04036_1 crossref_primary_10_1007_s10585_021_10104_z crossref_primary_10_3389_fimmu_2025_1601125 crossref_primary_10_1016_j_wneu_2018_11_100 crossref_primary_10_1093_neuonc_nox195 crossref_primary_10_3389_fonc_2019_00206 crossref_primary_10_1093_neuros_nyz428 crossref_primary_10_1016_j_ejso_2024_108676 crossref_primary_10_1016_j_wneu_2016_11_119 crossref_primary_10_1667_RR15517_1 crossref_primary_10_1016_j_wneu_2019_01_108 crossref_primary_10_1159_000478272 crossref_primary_10_1016_j_prro_2015_10_008 crossref_primary_10_1016_j_clineuro_2016_05_001 crossref_primary_10_1016_j_phro_2022_02_016 crossref_primary_10_1016_j_cllc_2017_01_013 crossref_primary_10_5507_bp_2016_058 crossref_primary_10_1002_acm2_13143 crossref_primary_10_1016_j_wneu_2015_02_035 crossref_primary_10_3390_cancers15194773 crossref_primary_10_1016_S1470_2045_13_70308_5 crossref_primary_10_1007_s00066_012_0093_4 crossref_primary_10_1016_j_critrevonc_2018_05_013 crossref_primary_10_1016_j_ijrobp_2013_07_034 crossref_primary_10_1016_j_intimp_2025_114837 crossref_primary_10_1227_neu_0000000000002456 crossref_primary_10_1016_j_prro_2017_06_014 crossref_primary_10_1007_s10585_020_10031_5 crossref_primary_10_1016_j_brachy_2020_11_004 crossref_primary_10_1016_j_prro_2013_09_006 crossref_primary_10_1007_s10269_012_2157_6 crossref_primary_10_1007_s11060_014_1501_7 crossref_primary_10_1007_s11060_023_04358_8 crossref_primary_10_1093_neuonc_now241 crossref_primary_10_1007_s11060_012_1016_z crossref_primary_10_1016_j_wneu_2015_03_057 crossref_primary_10_1007_s00330_016_4638_2 crossref_primary_10_1007_s11060_015_1855_5 crossref_primary_10_3389_fonc_2021_726613 crossref_primary_10_1016_j_critrevonc_2023_104015 crossref_primary_10_1136_jitc_2022_004509 crossref_primary_10_1007_s10143_024_03105_5 crossref_primary_10_1016_j_ijrobp_2012_08_008 crossref_primary_10_1016_j_ejso_2016_10_006 crossref_primary_10_1016_j_ijrobp_2012_08_007 crossref_primary_10_1002_acm2_13160 crossref_primary_10_1007_s12282_016_0672_9 crossref_primary_10_2147_CMAR_S251285 crossref_primary_10_3390_ijms15058138 crossref_primary_10_1007_s11060_024_04691_6 crossref_primary_10_1007_s11060_018_03008_8 crossref_primary_10_1016_j_jocn_2014_05_015 crossref_primary_10_1002_cncr_26515 crossref_primary_10_1007_s00066_020_01695_9 crossref_primary_10_1016_j_wneu_2015_03_052 crossref_primary_10_3390_medicina61081446 crossref_primary_10_1590_1806_9282_64_08_717 crossref_primary_10_1007_s00066_013_0326_1 crossref_primary_10_1007_s11060_018_2914_5 crossref_primary_10_3390_cancers15205067 crossref_primary_10_14694_EdBook_AM_2013_33_399 crossref_primary_10_3390_ijms26083828 crossref_primary_10_3390_cancers14163977 crossref_primary_10_1002_cncr_27835 crossref_primary_10_1016_j_clbc_2018_11_001 crossref_primary_10_1007_s00104_020_01344_y crossref_primary_10_1093_neuros_nyz442 crossref_primary_10_1111_1754_9485_12942 crossref_primary_10_1186_s13014_023_02216_5 crossref_primary_10_3390_cancers17152539 crossref_primary_10_1016_j_thorsurg_2021_04_001 crossref_primary_10_3171_2019_1_JNS182769 crossref_primary_10_1016_j_canrad_2011_02_008 crossref_primary_10_1016_j_ncl_2018_04_010 crossref_primary_10_3390_diagnostics14121268 crossref_primary_10_1016_j_canrad_2020_08_050 crossref_primary_10_1016_j_clon_2021_09_015 crossref_primary_10_1007_s11060_014_1373_x crossref_primary_10_1038_s41598_025_01034_x crossref_primary_10_1007_s11060_014_1601_4 crossref_primary_10_1016_j_ijrobp_2011_12_009 crossref_primary_10_1227_ONS_0000000000000101 crossref_primary_10_2217_cns_13_4 crossref_primary_10_1016_j_clon_2025_103847 crossref_primary_10_1016_j_radonc_2013_09_009 crossref_primary_10_1227_NEU_0b013e31826909f2 crossref_primary_10_1093_brain_awv094 crossref_primary_10_1097_PPO_0000000000000433 crossref_primary_10_1183_23120541_00109_2020 crossref_primary_10_1016_j_soc_2021_02_007 crossref_primary_10_1016_j_ijrobp_2011_12_017 crossref_primary_10_1007_s12094_012_0754_x crossref_primary_10_1016_j_wneu_2018_08_147 crossref_primary_10_1016_j_lungcan_2013_08_016 crossref_primary_10_1093_neuonc_nov186 crossref_primary_10_1093_neuros_nyz233 crossref_primary_10_1016_j_wneu_2017_07_062 crossref_primary_10_1093_neuros_nyy146 crossref_primary_10_1002_cam4_1149 crossref_primary_10_1007_s11060_020_03442_7 crossref_primary_10_1097_SPC_0b013e32834de694 crossref_primary_10_1093_nop_npaf040 crossref_primary_10_7759_cureus_679 crossref_primary_10_1002_ijc_34980 crossref_primary_10_1016_j_radonc_2011_08_041 crossref_primary_10_3109_02688697_2012_723170 crossref_primary_10_1097_COC_0000000000001093 crossref_primary_10_1016_j_clon_2019_07_004 crossref_primary_10_1093_annonc_mdx740 crossref_primary_10_1007_s00701_015_2479_4 crossref_primary_10_1016_j_canrad_2013_12_003 crossref_primary_10_1634_theoncologist_2012_0438 crossref_primary_10_3389_fonc_2021_772789 crossref_primary_10_7759_cureus_80025 crossref_primary_10_1016_j_ijrobp_2013_09_051 crossref_primary_10_3390_cancers16020291 crossref_primary_10_1001_jamanetworkopen_2020_8204 crossref_primary_10_1227_neu_0000000000002640 crossref_primary_10_1200_JCO_2014_58_4367 crossref_primary_10_1007_s12094_020_02550_0 crossref_primary_10_1097_CMR_0b013e328357be8f crossref_primary_10_1016_j_jtho_2017_07_006 crossref_primary_10_2217_crc_2016_0001 crossref_primary_10_1007_s00066_014_0625_1 crossref_primary_10_1007_s11060_012_0821_8 crossref_primary_10_1158_1078_0432_CCR_18_3049 crossref_primary_10_1007_s13665_018_0215_2 crossref_primary_10_1016_j_canrad_2018_05_006 crossref_primary_10_1093_neuonc_nov161 crossref_primary_10_1016_j_canrad_2013_06_030 crossref_primary_10_1007_s11060_013_1194_3 crossref_primary_10_1016_j_wneu_2017_07_048 crossref_primary_10_1007_s11060_012_0976_3 crossref_primary_10_3390_diagnostics13172853 crossref_primary_10_1016_j_ctrv_2017_02_004 crossref_primary_10_1016_j_ctro_2021_01_003 crossref_primary_10_3389_fonc_2023_1056330 crossref_primary_10_1016_j_bulcan_2016_02_005 crossref_primary_10_1007_s11060_016_2196_8 crossref_primary_10_1007_s11060_024_04738_8 crossref_primary_10_1016_j_canrad_2019_07_146 crossref_primary_10_3171_2020_10_JNS201934 crossref_primary_10_7759_cureus_16537 crossref_primary_10_1186_s13014_023_02214_7 crossref_primary_10_1016_j_ejso_2013_11_024 crossref_primary_10_1007_s11864_022_01013_8 crossref_primary_10_1007_s12094_013_1110_5 crossref_primary_10_1016_j_ctro_2022_05_008 crossref_primary_10_1227_neu_0000000000002626 crossref_primary_10_1016_j_ejca_2015_07_040 crossref_primary_10_7759_cureus_10011 crossref_primary_10_1038_nrclinonc_2014_25 crossref_primary_10_1007_s11864_019_0618_5 crossref_primary_10_1007_s11864_016_0400_x crossref_primary_10_1007_s00066_018_1405_0 crossref_primary_10_1097_PPO_0000000000000503 crossref_primary_10_3389_fonc_2022_857622 crossref_primary_10_1016_j_wneu_2020_07_150 crossref_primary_10_1016_S1470_2045_20_30034_6 crossref_primary_10_1093_neuonc_nov301 crossref_primary_10_1007_s00432_012_1227_x crossref_primary_10_3390_cancers13040603 crossref_primary_10_1007_s11060_021_03714_w crossref_primary_10_1016_j_wneu_2018_08_107 crossref_primary_10_1093_annonc_mdz056 crossref_primary_10_1016_j_sjbs_2021_05_017 crossref_primary_10_3171_2018_7_JNS181293 crossref_primary_10_1053_j_seminoncol_2020_07_001 crossref_primary_10_3171_2016_9_JNS161585 crossref_primary_10_1200_JCO_2015_63_9682 crossref_primary_10_1002_cam4_3402 crossref_primary_10_1007_s11912_019_0803_5 crossref_primary_10_1016_j_annonc_2021_12_005 crossref_primary_10_1007_s10585_020_10035_1 crossref_primary_10_1016_j_ctro_2023_100723 crossref_primary_10_1016_j_radonc_2024_110331 crossref_primary_10_1002_cncr_30984 crossref_primary_10_1016_j_clon_2012_03_008 crossref_primary_10_1016_j_hoc_2012_04_001 crossref_primary_10_3322_caac_21729 crossref_primary_10_3390_cancers14112736 crossref_primary_10_1007_s11812_012_0052_0 crossref_primary_10_1007_s13566_018_0353_8 crossref_primary_10_1093_oncolo_oyac064 crossref_primary_10_1007_s11060_015_1789_y crossref_primary_10_1016_j_hoc_2012_04_008 crossref_primary_10_1007_s12609_011_0061_5 crossref_primary_10_1016_j_ejca_2020_10_013 crossref_primary_10_1002_cam4_1477 crossref_primary_10_5301_tj_5000657 crossref_primary_10_1007_s11060_013_1093_7 crossref_primary_10_1016_j_canrad_2021_01_007 crossref_primary_10_1007_s11654_019_0148_4 crossref_primary_10_1016_j_canrad_2013_07_134 crossref_primary_10_1016_j_ctro_2018_11_006 crossref_primary_10_1016_j_canrad_2013_07_139 crossref_primary_10_1007_s10143_023_02031_2 crossref_primary_10_1016_j_ctro_2021_11_008 crossref_primary_10_1186_s13014_020_01522_6 crossref_primary_10_1007_s00066_017_1185_y crossref_primary_10_1016_j_clon_2022_08_024 crossref_primary_10_1186_s13014_020_01644_x crossref_primary_10_1002_cam4_2577 crossref_primary_10_1097_PPO_0000000000000754 crossref_primary_10_3390_cancers16223780 crossref_primary_10_1002_cam4_1486 crossref_primary_10_1016_j_clon_2014_06_010 crossref_primary_10_1007_s10549_023_06936_w crossref_primary_10_1097_CCO_0000000000000682 crossref_primary_10_1007_s11060_019_03368_9 crossref_primary_10_1093_neuros_nyx429 crossref_primary_10_3389_fonc_2018_00415 crossref_primary_10_2217_fon_13_90 crossref_primary_10_1016_j_canrad_2014_10_008 crossref_primary_10_1097_COC_0000000000000299 crossref_primary_10_1016_j_wneu_2018_10_193 crossref_primary_10_1016_j_prro_2014_03_006 crossref_primary_10_1016_j_rpor_2018_02_005 crossref_primary_10_1097_COC_0000000000000296 crossref_primary_10_1080_14737140_2019_1582336 crossref_primary_10_1007_s12094_017_1703_5 crossref_primary_10_1016_j_ctarc_2025_100983 crossref_primary_10_1002_nbm_3163 crossref_primary_10_1016_j_prro_2021_01_011 crossref_primary_10_1093_neuonc_noae076 crossref_primary_10_1007_s10585_020_10068_6 crossref_primary_10_3390_cancers16061174 crossref_primary_10_3390_cancers15010211 crossref_primary_10_1002_ijc_33243 crossref_primary_10_1016_j_prro_2015_11_004 crossref_primary_10_1038_s41571_024_00970_3 crossref_primary_10_1684_bdc_2012_1613 crossref_primary_10_1007_s10585_020_10022_6 crossref_primary_10_1016_S1470_2045_14_70076_2 crossref_primary_10_1093_neuros_nyy543 crossref_primary_10_1155_2012_276189 crossref_primary_10_1093_neuros_nyy541 crossref_primary_10_1007_s11060_013_1191_6 crossref_primary_10_1053_j_seminoncol_2014_09_016 crossref_primary_10_1007_s10585_012_9542_9 crossref_primary_10_1007_s00701_025_06520_9 crossref_primary_10_3390_ijms19092653 crossref_primary_10_1007_s00432_020_03334_3 crossref_primary_10_1016_j_ijrobp_2016_06_009 crossref_primary_10_1007_s11060_023_04407_2 crossref_primary_10_1007_s00701_013_1821_y crossref_primary_10_1007_s11060_014_1435_0 crossref_primary_10_1089_thy_2015_0020 crossref_primary_10_1002_cncr_32714 crossref_primary_10_1007_s11060_015_1767_4 crossref_primary_10_1016_j_clon_2023_02_012 crossref_primary_10_1007_s40263_018_0526_4 crossref_primary_10_1007_s00066_016_1009_5 crossref_primary_10_1016_j_critrevonc_2020_102946 crossref_primary_10_1111_1754_9485_13447 crossref_primary_10_1016_j_clon_2020_06_018 crossref_primary_10_1093_neuros_nyy548 crossref_primary_10_1038_s41598_021_87357_x crossref_primary_10_1016_j_wneu_2022_03_028 crossref_primary_10_1007_s12094_021_02607_8 crossref_primary_10_1016_j_psym_2017_04_004 crossref_primary_10_1038_s41591_024_03261_7 crossref_primary_10_1371_journal_pone_0198692 crossref_primary_10_1245_s10434_016_5709_y crossref_primary_10_1055_a_2519_6707 crossref_primary_10_1016_j_clon_2017_12_020 crossref_primary_10_1007_s00432_021_03564_z crossref_primary_10_1007_s12254_014_0181_5 crossref_primary_10_3389_fnins_2021_738708 crossref_primary_10_1016_j_ijrobp_2014_03_001 crossref_primary_10_1155_2011_845863 crossref_primary_10_3109_02688697_2012_690913 crossref_primary_10_4103_jmp_jmp_62_23 crossref_primary_10_1007_s11060_018_2965_7 crossref_primary_10_1016_j_rpor_2013_03_002 crossref_primary_10_1097_MD_0000000000007698 crossref_primary_10_1186_s13014_015_0466_9 crossref_primary_10_2217_mmt_2016_0004 crossref_primary_10_1186_s13014_015_0553_y crossref_primary_10_3390_cancers13236086 crossref_primary_10_2217_pme_2017_0087 crossref_primary_10_1016_j_ijrobp_2014_06_063 crossref_primary_10_1016_j_molmed_2024_09_008 crossref_primary_10_1212_CON_0000000000001354 crossref_primary_10_1007_s12312_022_01124_1 crossref_primary_10_1186_s13014_015_0431_7 crossref_primary_10_1016_j_ijrobp_2017_03_012 crossref_primary_10_3171_2015_2_JNS141993 crossref_primary_10_3390_ijms15046910 crossref_primary_10_1007_s11060_018_2954_x crossref_primary_10_3171_2015_10_JNS15801 crossref_primary_10_1002_cncr_29590 crossref_primary_10_1007_s10585_016_9778_x crossref_primary_10_1038_s41571_019_0320_3 crossref_primary_10_1016_j_ijrobp_2016_09_043 crossref_primary_10_1007_s15005_015_1217_z crossref_primary_10_1089_ct_2021_33_410_413 crossref_primary_10_1093_neuonc_noaa092 crossref_primary_10_1227_NEU_0000000000000289 crossref_primary_10_1186_1748_717X_8_204 crossref_primary_10_2217_cns_2018_0016 crossref_primary_10_1016_j_clineuro_2016_02_039 crossref_primary_10_1007_s11060_011_0607_4 crossref_primary_10_1016_S1470_2045_13_70311_5 crossref_primary_10_1007_s00129_017_4162_8 crossref_primary_10_1038_s41598_021_88070_5 crossref_primary_10_1080_14737140_2016_1190648 crossref_primary_10_1007_s10585_015_9699_0 crossref_primary_10_3390_cancers15061790 crossref_primary_10_1038_srep45193 crossref_primary_10_1111_iwj_12993 crossref_primary_10_1177_15330338241273324 crossref_primary_10_2217_cer_13_50 crossref_primary_10_1007_s40257_018_0346_9 crossref_primary_10_1080_14737140_2020_1770601 crossref_primary_10_1007_s10585_015_9762_x crossref_primary_10_1007_s00761_013_2560_7 crossref_primary_10_1016_j_clineuro_2016_01_008 crossref_primary_10_1158_1078_0432_CCR_18_1624 crossref_primary_10_1007_s11060_011_0697_z crossref_primary_10_1007_s00701_016_2707_6 crossref_primary_10_1007_s11060_016_2254_2 crossref_primary_10_1016_S1470_2045_17_30441_2 crossref_primary_10_4103_0028_3886_373651 crossref_primary_10_3389_fonc_2018_00241 crossref_primary_10_1007_s11060_019_03106_1 crossref_primary_10_1093_jjco_hyu156 crossref_primary_10_3171_2016_10_JNS161480 crossref_primary_10_12688_f1000research_15903_1 crossref_primary_10_1016_j_canrad_2021_06_019 crossref_primary_10_1016_j_ijrobp_2012_01_028 crossref_primary_10_1007_s13566_018_0368_1 crossref_primary_10_1093_neuonc_noz049 crossref_primary_10_1016_j_ijrobp_2017_03_030 crossref_primary_10_1016_j_jrras_2023_100719 crossref_primary_10_1016_j_jocn_2022_03_024 crossref_primary_10_1016_j_ijrobp_2014_05_047 crossref_primary_10_1016_j_nec_2020_05_002 crossref_primary_10_1016_j_nec_2020_05_001 crossref_primary_10_1007_s15016_014_0023_z crossref_primary_10_3389_fonc_2023_1343500 crossref_primary_10_1186_1471_2407_11_142 crossref_primary_10_1007_s00520_013_1917_1 crossref_primary_10_2217_cns_14_51 crossref_primary_10_1007_s11060_014_1388_3 crossref_primary_10_3892_ol_2016_4349 crossref_primary_10_1002_jso_27883 crossref_primary_10_1016_j_clineuro_2016_01_011 crossref_primary_10_1186_s12885_020_07011_z crossref_primary_10_1016_j_soc_2017_01_003 crossref_primary_10_1148_rg_2020190138 crossref_primary_10_1007_s11864_013_0248_2 crossref_primary_10_3389_fonc_2024_1333245 crossref_primary_10_1016_j_semradonc_2014_11_005 crossref_primary_10_1227_NEU_0000000000000072 crossref_primary_10_1093_neuonc_noac249 crossref_primary_10_1016_j_clon_2020_02_001 crossref_primary_10_1155_2012_952345 crossref_primary_10_1016_j_tipsro_2021_11_004 crossref_primary_10_1093_neuonc_noab159 crossref_primary_10_1093_annonc_mdx481 crossref_primary_10_1111_ijcp_12395 crossref_primary_10_3389_fonc_2016_00040 crossref_primary_10_1016_j_clineuro_2013_06_006 crossref_primary_10_3389_fonc_2018_00065 crossref_primary_10_1016_j_jocn_2013_07_043 crossref_primary_10_1016_j_clon_2018_09_005 crossref_primary_10_1016_j_ejca_2012_07_002 crossref_primary_10_1007_s11060_020_03492_x crossref_primary_10_1186_s12885_021_08129_4 crossref_primary_10_2217_mmt_15_16 crossref_primary_10_2147_CMAR_S272369 crossref_primary_10_1007_s11060_018_03066_y crossref_primary_10_1097_COC_0000000000000441 crossref_primary_10_1016_j_jocn_2011_04_002 crossref_primary_10_1227_NEU_0b013e3182889ddf crossref_primary_10_1007_s10143_024_02666_9 crossref_primary_10_1093_nop_npab005 crossref_primary_10_1007_s11864_013_0228_6 crossref_primary_10_1016_j_ctro_2024_100811 crossref_primary_10_1177_1578_17210 crossref_primary_10_1186_s13014_015_0555_9 crossref_primary_10_1007_s10143_018_0963_z crossref_primary_10_1097_MD_0000000000037084 crossref_primary_10_1586_14737140_2014_940325 crossref_primary_10_1684_bdc_2012_1683 crossref_primary_10_1001_jama_2016_9839 crossref_primary_10_1684_bdc_2012_1682 crossref_primary_10_1186_1748_717X_6_48 crossref_primary_10_1016_j_neurol_2011_01_017 crossref_primary_10_1097_RLI_0b013e318277f078 crossref_primary_10_1186_1748_717X_8_234 crossref_primary_10_1186_s12885_022_10480_z crossref_primary_10_1007_s11060_017_2588_4 crossref_primary_10_1007_s00066_022_01913_6 crossref_primary_10_1053_j_seminoncol_2019_07_004 crossref_primary_10_1186_s13014_014_0267_6 crossref_primary_10_1016_j_clineuro_2021_107016 crossref_primary_10_1016_j_cllc_2024_06_004 crossref_primary_10_1016_j_wneu_2023_10_079 crossref_primary_10_1093_neuonc_noae219 crossref_primary_10_1007_s11547_022_01489_2 crossref_primary_10_1259_bjr_20200951 crossref_primary_10_1155_2022_6531748 crossref_primary_10_1016_j_ijrobp_2018_10_038 crossref_primary_10_1016_j_wneu_2011_01_036 crossref_primary_10_1007_s11060_020_03657_8 crossref_primary_10_3171_2016_4_JNS152319 crossref_primary_10_1017_S1460396919000268 crossref_primary_10_1684_bdc_2012_1675 crossref_primary_10_1016_j_ijrobp_2017_02_031 crossref_primary_10_1016_j_radonc_2017_03_018 crossref_primary_10_1007_s00761_023_01361_6 crossref_primary_10_1016_j_jtocrr_2021_100274 crossref_primary_10_1016_j_radonc_2014_07_007 crossref_primary_10_1097_RCT_0000000000001006 crossref_primary_10_1093_neuonc_noae220 crossref_primary_10_1002_cncr_32787 crossref_primary_10_1016_j_nec_2020_06_006 crossref_primary_10_1097_CCO_0000000000000484 crossref_primary_10_1186_s12885_023_11739_9 crossref_primary_10_23736_S0390_5616_20_04952_8 crossref_primary_10_1007_s00115_014_4242_0 crossref_primary_10_1016_j_ejca_2018_01_067 crossref_primary_10_1186_1748_717X_7_130 crossref_primary_10_1259_bjr_20160666 crossref_primary_10_3390_cancers15204948 crossref_primary_10_1007_s00761_013_2563_4 crossref_primary_10_3390_cancers15030780 crossref_primary_10_1007_s00066_013_0334_1 crossref_primary_10_1186_s13014_020_01517_3 crossref_primary_10_1016_j_jneuroim_2017_10_006 crossref_primary_10_1007_s11654_013_0071_z crossref_primary_10_3389_fonc_2022_1060570 crossref_primary_10_1007_s00761_022_01123_w crossref_primary_10_3390_cancers15194817 crossref_primary_10_2217_cns_12_33 crossref_primary_10_1093_neuonc_noaa233 crossref_primary_10_4103_IJNO_IJNO_14_20 crossref_primary_10_1007_s10143_018_1013_6 crossref_primary_10_1016_j_trsl_2019_02_011 crossref_primary_10_1002_pbc_29331 crossref_primary_10_3892_mco_2016_772 crossref_primary_10_1007_s00761_018_0375_2 crossref_primary_10_1093_neuonc_noaa239 crossref_primary_10_1007_s00701_015_2405_9 crossref_primary_10_1093_annonc_mdw328 crossref_primary_10_1002_mp_15294 crossref_primary_10_1007_s10072_012_1091_0 crossref_primary_10_3390_cancers14205136 crossref_primary_10_1016_j_jocn_2024_05_011 crossref_primary_10_1016_j_ctro_2019_02_005 crossref_primary_10_1200_JCO_2017_75_9589 crossref_primary_10_1053_j_ro_2017_11_008 crossref_primary_10_1159_000502755 crossref_primary_10_1093_jnci_djv305 crossref_primary_10_1001_jamanetworkopen_2022_25459 crossref_primary_10_1016_j_radonc_2013_11_015 crossref_primary_10_1093_neuonc_noaa244 crossref_primary_10_1186_1748_717X_8_162 crossref_primary_10_3390_medicines5030090 crossref_primary_10_1016_j_radonc_2018_04_007 crossref_primary_10_1016_j_ejca_2014_01_001 crossref_primary_10_1093_neuonc_nov093 crossref_primary_10_1177_1778_19280 crossref_primary_10_1016_j_clineuro_2014_07_030 crossref_primary_10_1186_1748_717X_8_156 crossref_primary_10_1093_neuros_nyaa075 crossref_primary_10_1016_j_ccell_2015_01_001 crossref_primary_10_1093_neuros_nyaa076 crossref_primary_10_1097_CMR_0000000000000268 crossref_primary_10_1007_s40263_012_0024_z crossref_primary_10_1016_j_ctrv_2013_05_002 crossref_primary_10_1038_s41598_020_63158_6 crossref_primary_10_1002_cnr2_1414 crossref_primary_10_3390_cancers13081857 crossref_primary_10_1186_s13014_023_02383_5 crossref_primary_10_1088_1361_6560_aaa517 crossref_primary_10_1007_s00066_016_0955_2 crossref_primary_10_1007_s10585_021_10114_x crossref_primary_10_1093_neuonc_nov089 crossref_primary_10_1007_s00761_022_01230_8 crossref_primary_10_1186_1756_0500_7_412 crossref_primary_10_1016_S0140_6736_16_31391_5 crossref_primary_10_1007_s11060_016_2103_3 crossref_primary_10_1016_j_canrad_2024_09_005 crossref_primary_10_1016_j_ijrobp_2020_02_639 crossref_primary_10_1007_s11060_017_2707_2 crossref_primary_10_1016_j_radonc_2018_12_018 crossref_primary_10_1016_j_wneu_2018_05_039 crossref_primary_10_3389_fonc_2022_827304 crossref_primary_10_1016_j_canrad_2014_12_004 crossref_primary_10_1684_bdc_2012_1596 crossref_primary_10_1111_ajco_70029 crossref_primary_10_1142_S1793545825300058 crossref_primary_10_1200_JCO_2013_49_3478 crossref_primary_10_1016_j_ijrobp_2015_10_017 crossref_primary_10_1038_nrclinonc_2010_119_c1 crossref_primary_10_1016_j_cdtm_2017_01_004 crossref_primary_10_1007_s12032_017_0978_2 crossref_primary_10_1007_s10555_015_9559_z crossref_primary_10_3390_cancers13184711 crossref_primary_10_3390_ijms15057554 crossref_primary_10_1259_bjr_20170022 crossref_primary_10_1016_j_ijrobp_2011_09_032 crossref_primary_10_1093_neuros_nyz162 crossref_primary_10_1016_S2213_2600_17_30262_X crossref_primary_10_1007_s15015_013_0510_2 crossref_primary_10_1016_S1470_2045_18_30439_X crossref_primary_10_1093_neuonc_now184 crossref_primary_10_3174_ajnr_A8431 crossref_primary_10_1016_j_critrevonc_2020_103028 crossref_primary_10_1200_JCO_2016_70_9287 crossref_primary_10_1093_neuonc_nox090 crossref_primary_10_1007_s11060_019_03309_6 crossref_primary_10_1016_j_ejca_2011_10_016 crossref_primary_10_1016_j_ctro_2024_100782 crossref_primary_10_1089_thy_2013_0061 crossref_primary_10_1227_neu_0000000000003239 crossref_primary_10_1016_j_ctro_2024_100783 crossref_primary_10_1007_s00432_018_2781_7 crossref_primary_10_1016_j_bbcan_2012_10_005 crossref_primary_10_1007_s11060_014_1550_y crossref_primary_10_1007_s00066_022_01916_3 crossref_primary_10_1007_s11060_016_2334_3 crossref_primary_10_3171_2016_5_JNS153051 crossref_primary_10_1002_cncr_26612 crossref_primary_10_1016_j_amjmed_2017_12_039 crossref_primary_10_1016_j_annonc_2024_08_2347 crossref_primary_10_1016_j_ejca_2018_07_004 crossref_primary_10_1159_000488151 crossref_primary_10_1016_j_ejca_2018_07_002 crossref_primary_10_1016_j_ctrv_2016_03_014 crossref_primary_10_1186_s12885_021_08602_0 crossref_primary_10_1093_neuonc_noab129 crossref_primary_10_1002_jso_21837 crossref_primary_10_1016_j_jocn_2016_12_006 crossref_primary_10_3390_ijms21228534 crossref_primary_10_3892_ol_2016_4440 crossref_primary_10_1016_j_ijrobp_2021_05_124 crossref_primary_10_1200_JCO_2018_79_3232 crossref_primary_10_3389_fonc_2015_00110 crossref_primary_10_1016_j_radonc_2016_10_005 crossref_primary_10_1177_1533034616685025 crossref_primary_10_1080_02688697_2020_1817856 crossref_primary_10_1016_j_ijrobp_2017_04_006 crossref_primary_10_1007_s11864_013_0258_0 crossref_primary_10_1007_s11940_019_0548_3 crossref_primary_10_1016_j_ctrv_2013_06_004 crossref_primary_10_3390_cancers2042100 crossref_primary_10_1007_s11060_014_1670_4 crossref_primary_10_3390_cancers12113293 crossref_primary_10_1186_s12885_016_2433_8 crossref_primary_10_1007_s00066_016_1012_x crossref_primary_10_3389_fimmu_2022_746869 crossref_primary_10_1097_PPO_0000000000000146 crossref_primary_10_1016_j_prro_2021_04_002 crossref_primary_10_3171_2020_8_JNS201810 crossref_primary_10_3390_cancers15143670 crossref_primary_10_1007_s11060_020_03485_w crossref_primary_10_1111_ajco_12124 crossref_primary_10_1093_annonc_mdy554 crossref_primary_10_1016_S1634_7072_12_62058_3 crossref_primary_10_1200_JCO_2010_33_3294 crossref_primary_10_1016_j_clon_2015_06_005 crossref_primary_10_1016_j_critrevonc_2021_103329 crossref_primary_10_1016_j_ijrobp_2019_08_054 crossref_primary_10_1016_j_ijrobp_2015_11_022 crossref_primary_10_1097_SPC_0b013e328350f70c crossref_primary_10_1007_s11060_014_1519_x crossref_primary_10_1016_j_radonc_2021_03_022 crossref_primary_10_1016_j_prro_2015_08_001 crossref_primary_10_1186_s13014_020_01717_x crossref_primary_10_1227_neu_0000000000002372 crossref_primary_10_1016_S1470_2045_17_30703_9 crossref_primary_10_1093_neuonc_noab101 crossref_primary_10_1002_acm2_13484 crossref_primary_10_1097_SPC_0b013e32834de714 crossref_primary_10_3171_2017_9_JNS171735 crossref_primary_10_1159_000362389 crossref_primary_10_1016_j_wneu_2015_07_073 crossref_primary_10_1016_j_ijrobp_2012_05_027 crossref_primary_10_1016_j_ijrobp_2012_05_047 crossref_primary_10_1055_a_2238_1840 crossref_primary_10_1186_s12943_023_01818_7 crossref_primary_10_1016_j_neuchi_2014_05_002 crossref_primary_10_1016_S1470_2045_17_30693_9 crossref_primary_10_4103_0028_3886_319199 crossref_primary_10_1080_2162402X_2016_1172153 crossref_primary_10_1002_acm2_14343 crossref_primary_10_1016_j_jocn_2018_09_029 crossref_primary_10_1016_j_canrad_2014_11_009 crossref_primary_10_1016_j_prro_2016_01_002 crossref_primary_10_1016_j_wneu_2019_11_089 crossref_primary_10_1016_j_wneu_2016_02_007 crossref_primary_10_1093_neuonc_nox077 crossref_primary_10_1016_j_ejca_2021_07_032 crossref_primary_10_1186_s13014_017_0804_1 crossref_primary_10_1200_EDBK_175338 crossref_primary_10_1038_s41467_024_47998_8 crossref_primary_10_3390_jpm10030059 crossref_primary_10_1016_j_meddos_2017_06_007 crossref_primary_10_1080_14656566_2018_1472765 crossref_primary_10_1200_JCO_2012_42_6429 crossref_primary_10_23938_ASSN_0265 crossref_primary_10_3390_ijms19103054 crossref_primary_10_3390_life13061293 crossref_primary_10_1016_j_jocn_2012_09_011 crossref_primary_10_1007_s00761_011_2014_z crossref_primary_10_1177_1559325820938279 crossref_primary_10_1093_neuonc_now116 crossref_primary_10_1016_j_canrad_2012_03_010 crossref_primary_10_1200_EDBK_175570 crossref_primary_10_1016_j_ijrobp_2017_07_033 crossref_primary_10_1586_14737140_2014_863468 crossref_primary_10_1007_s11060_012_0868_6 crossref_primary_10_3390_cancers16061093 crossref_primary_10_1007_s00432_020_03152_7 crossref_primary_10_1007_s11060_017_2394_z crossref_primary_10_1007_s11912_018_0695_9 crossref_primary_10_1093_neuros_nyx376 crossref_primary_10_36290_xon_2019_032 crossref_primary_10_1093_neuros_nyy222 crossref_primary_10_23736_S1824_4785_19_03173_X crossref_primary_10_1007_s11060_024_04790_4 crossref_primary_10_1016_j_prro_2016_04_004 crossref_primary_10_3390_cancers15184622 crossref_primary_10_1016_j_breast_2015_03_007 crossref_primary_10_3390_cancers13071616 crossref_primary_10_1186_1748_717X_6_175 crossref_primary_10_1093_neuonc_now127 crossref_primary_10_1007_s12094_020_02333_7 crossref_primary_10_1016_j_heliyon_2024_e29350 crossref_primary_10_1002_jmrs_526 crossref_primary_10_1016_j_ijrobp_2015_03_003 crossref_primary_10_1093_neuros_nyy216 crossref_primary_10_1007_s12609_015_0191_2 crossref_primary_10_1016_j_jtho_2016_06_002 crossref_primary_10_1186_s13014_017_0948_z crossref_primary_10_1016_j_ijrobp_2015_04_036 crossref_primary_10_1227_NEU_0000000000000750 crossref_primary_10_1016_j_wneu_2017_04_103 crossref_primary_10_1259_bjr_20170099 crossref_primary_10_1186_s13014_019_1255_7 crossref_primary_10_1038_s41572_018_0055_y crossref_primary_10_1007_s10143_017_0931_z crossref_primary_10_1016_j_ijrobp_2014_09_004 crossref_primary_10_1186_s40425_019_0588_y crossref_primary_10_1200_JCO_2013_54_0955 crossref_primary_10_1016_j_ijrobp_2012_05_002 crossref_primary_10_1016_j_jocn_2012_09_026 crossref_primary_10_1186_s40164_015_0028_8 crossref_primary_10_1016_j_wneu_2017_05_131 crossref_primary_10_1186_1748_717X_7_181 crossref_primary_10_7759_cureus_60368 crossref_primary_10_1186_1748_717X_6_158 crossref_primary_10_1016_j_canrad_2014_06_018 crossref_primary_10_1007_s11912_011_0205_9 crossref_primary_10_1016_j_breast_2024_103675 crossref_primary_10_3389_fonc_2020_00693 crossref_primary_10_1007_s00066_019_01475_0 crossref_primary_10_1016_j_bulcan_2017_11_003 crossref_primary_10_1007_s00432_012_1218_y crossref_primary_10_1016_j_brachy_2019_01_011 crossref_primary_10_1016_j_clineuro_2015_12_009 crossref_primary_10_1186_1748_717X_7_188 crossref_primary_10_2217_fon_2019_0180 crossref_primary_10_1016_j_lungcan_2016_04_003 crossref_primary_10_1007_s10269_016_2636_2 crossref_primary_10_1007_s11060_014_1417_2 crossref_primary_10_1016_j_canrad_2017_04_014 crossref_primary_10_1227_neu_0000000000002542 crossref_primary_10_3109_02688697_2013_791666 crossref_primary_10_1200_JCO_2015_62_0138 crossref_primary_10_1016_j_wneu_2016_06_098 crossref_primary_10_3390_cancers15092432 crossref_primary_10_1016_j_ando_2025_101790 crossref_primary_10_1016_j_meddos_2017_07_005 crossref_primary_10_3171_2021_7_JNS211172 crossref_primary_10_7887_jcns_33_178 crossref_primary_10_1093_neuonc_nox001 crossref_primary_10_1016_j_breast_2018_06_011 crossref_primary_10_14694_EdBook_AM_2015_35_e99 crossref_primary_10_1093_annonc_mdu104 crossref_primary_10_1080_0284186X_2019_1633016 crossref_primary_10_1093_neuros_nyy026 crossref_primary_10_3390_cancers16244207 crossref_primary_10_1093_annonc_mdu584 crossref_primary_10_1093_neuros_nyy021 crossref_primary_10_1007_s11060_013_1071_0 crossref_primary_10_1177_030089161209800218 crossref_primary_10_1016_j_canrad_2019_06_012 crossref_primary_10_1097_CMR_0000000000000670 crossref_primary_10_1016_j_prro_2025_01_012 crossref_primary_10_1080_02688697_2021_1950623 crossref_primary_10_1227_NEU_0000000000000763 crossref_primary_10_1016_j_jocn_2024_02_020 crossref_primary_10_1016_j_canrad_2019_12_002 crossref_primary_10_1016_j_breast_2016_10_006 crossref_primary_10_1016_j_lungcan_2018_12_009 crossref_primary_10_1634_theoncologist_2012_0316 crossref_primary_10_1016_j_soncn_2023_151567 crossref_primary_10_1007_s11547_014_0383_2 crossref_primary_10_1038_nrclinonc_2011_179 crossref_primary_10_1007_s11060_015_1932_9 crossref_primary_10_1007_s11864_020_00733_z crossref_primary_10_1159_000358750 crossref_primary_10_1093_neuonc_nov286 crossref_primary_10_3171_2021_10_JNS211886 crossref_primary_10_1016_j_wneu_2016_11_010 crossref_primary_10_3171_2018_10_JNS181371 crossref_primary_10_1007_s00066_014_0648_7 crossref_primary_10_1111_pcmr_12775 crossref_primary_10_3892_ijo_2015_2970 crossref_primary_10_3390_cancers16223746 crossref_primary_10_3109_09553002_2014_925607 crossref_primary_10_1016_j_clbc_2024_04_001 crossref_primary_10_1007_s00761_013_2558_1 crossref_primary_10_1016_j_jtho_2016_05_013 crossref_primary_10_1016_j_clon_2024_103697 crossref_primary_10_1016_j_clineuro_2019_105389 crossref_primary_10_1016_S1470_2045_21_00716_6 crossref_primary_10_1186_s13014_022_02096_1 crossref_primary_10_1016_j_brachy_2023_08_002 crossref_primary_10_36290_xon_2018_025 crossref_primary_10_1007_s13566_012_0043_x crossref_primary_10_1007_s11912_019_0817_z crossref_primary_10_1093_neuonc_now149 crossref_primary_10_1007_s12032_017_0919_0 crossref_primary_10_1016_j_ijrobp_2017_07_045 crossref_primary_10_1111_1759_7714_14532 crossref_primary_10_1155_2012_493426 crossref_primary_10_1038_s41598_020_61354_y crossref_primary_10_1186_s13014_022_02086_3 crossref_primary_10_1007_s11060_020_03663_w crossref_primary_10_1186_s13014_021_01802_9 crossref_primary_10_1111_apm_13402 crossref_primary_10_1016_j_critrevonc_2017_05_007 crossref_primary_10_1016_j_clon_2015_01_007 crossref_primary_10_1016_j_prro_2011_12_004 crossref_primary_10_1016_j_clgc_2018_11_006 crossref_primary_10_1097_CCO_0000000000000326 crossref_primary_10_1002_cncr_29642 crossref_primary_10_1007_s11912_011_0201_0 crossref_primary_10_1016_j_radonc_2014_01_012 crossref_primary_10_1227_NEU_0000000000000332 crossref_primary_10_1097_CCO_0000000000000573 crossref_primary_10_1002_cncr_26379 crossref_primary_10_1080_2162402X_2016_1214788 crossref_primary_10_3389_fonc_2020_559193 crossref_primary_10_1007_s10143_016_0760_5 crossref_primary_10_1111_1754_9485_13504 crossref_primary_10_1016_j_ctrv_2020_102083 crossref_primary_10_1007_s10549_020_05552_2 crossref_primary_10_1001_jamanetworkopen_2023_0475 crossref_primary_10_1177_0300891618765541 crossref_primary_10_1227_NEU_0000000000000325 crossref_primary_10_1089_jpm_2015_0097 crossref_primary_10_1016_j_ctro_2021_03_003 crossref_primary_10_1016_j_canrad_2020_06_013 crossref_primary_10_1016_j_semradonc_2023_01_004 crossref_primary_10_2147_OTT_S520700 crossref_primary_10_1016_j_semradonc_2023_01_005 crossref_primary_10_1007_s00761_014_2680_8 crossref_primary_10_1016_j_cllc_2017_06_011 crossref_primary_10_2217_fon_2019_0119 crossref_primary_10_1007_s11060_012_0912_6 crossref_primary_10_1159_000350920 crossref_primary_10_1016_j_wneu_2012_05_009 crossref_primary_10_3389_fonc_2018_00551 crossref_primary_10_1007_s11060_021_03702_0 crossref_primary_10_1016_j_currproblcancer_2015_03_001 crossref_primary_10_3171_2013_4_JNS121751 crossref_primary_10_1002_cncr_28307 crossref_primary_10_1016_j_jocn_2017_02_023 crossref_primary_10_1097_RLI_0b013e3182319704 crossref_primary_10_1016_j_ctro_2021_03_012 crossref_primary_10_1200_JCO_2013_53_7365 crossref_primary_10_1016_j_ctro_2017_09_007 crossref_primary_10_1007_s10143_016_0718_7 crossref_primary_10_1007_s11060_015_1962_3 crossref_primary_10_3390_cancers13010070 crossref_primary_10_1093_neuros_nyx522 crossref_primary_10_1007_s11095_018_2455_9 crossref_primary_10_1007_s11604_022_01333_7 crossref_primary_10_1097_COC_0000000000000199 crossref_primary_10_1001_jamanetworkopen_2022_28083 crossref_primary_10_1007_s11060_018_2968_4 crossref_primary_10_1007_s11940_013_0276_z crossref_primary_10_1017_S1460396921000029 crossref_primary_10_1093_nop_npz004 crossref_primary_10_1186_s12885_016_2989_3 crossref_primary_10_1002_cncr_30607 crossref_primary_10_1007_s11060_025_05038_5 crossref_primary_10_1016_j_wneu_2022_12_079 crossref_primary_10_1093_neuonc_noae140 crossref_primary_10_1007_s11060_010_0514_0 crossref_primary_10_1227_NEU_0000000000000354 crossref_primary_10_1016_j_jocn_2015_05_019 crossref_primary_10_1007_s00761_013_2590_1 crossref_primary_10_1007_s13566_012_0052_9 crossref_primary_10_1186_s13063_022_06826_4 crossref_primary_10_1097_JTO_0b013e318262caf6 crossref_primary_10_1200_JCO_2012_46_0410 crossref_primary_10_1016_j_clineuro_2021_106645 crossref_primary_10_1016_j_ijrobp_2018_03_032 crossref_primary_10_7785_tcrt_2012_500344 crossref_primary_10_1007_s00066_014_0639_8 crossref_primary_10_1016_j_radonc_2018_01_005 crossref_primary_10_1227_NEU_0000000000001436 crossref_primary_10_1227_neu_0000000000002716 crossref_primary_10_1097_CMR_0000000000000816 crossref_primary_10_3109_0284186X_2014_921724 crossref_primary_10_1016_j_canrad_2018_08_001 crossref_primary_10_1016_j_cllc_2025_07_019 crossref_primary_10_3390_cancers15123193 crossref_primary_10_1007_s12094_024_03844_3 crossref_primary_10_1227_NEU_0000000000000584 crossref_primary_10_1002_cncr_26343 crossref_primary_10_25259_SNI_166_2019 crossref_primary_10_3171_2017_3_JNS162532 crossref_primary_10_1016_j_nicl_2018_08_024 crossref_primary_10_1093_jjco_hyab182 crossref_primary_10_1080_14737140_2016_1229600 crossref_primary_10_3390_cancers11081092 crossref_primary_10_1016_j_critrevonc_2012_04_001 crossref_primary_10_7785_tcrt_2012_500336 crossref_primary_10_1016_j_ctrv_2021_102324 crossref_primary_10_1016_j_ctrv_2016_08_003 crossref_primary_10_3390_cancers15184496 crossref_primary_10_1056_NEJMcpc1302332 crossref_primary_10_1016_j_ijrobp_2015_04_015 crossref_primary_10_1016_j_prro_2015_03_007 crossref_primary_10_1186_s12885_017_3672_z crossref_primary_10_1016_j_ijrobp_2015_04_012 crossref_primary_10_1007_s11060_016_2275_x crossref_primary_10_1186_s41016_018_0149_0 crossref_primary_10_1016_j_rpor_2015_12_001 crossref_primary_10_1097_MD_0000000000016653 crossref_primary_10_1155_2012_294735 crossref_primary_10_3390_cancers16234122 crossref_primary_10_1007_s11547_023_01698_3 crossref_primary_10_1007_s11060_011_0613_6 crossref_primary_10_1016_j_ijrobp_2018_03_056 crossref_primary_10_1007_s00701_020_04658_2 crossref_primary_10_1016_j_jocn_2017_08_028 crossref_primary_10_1007_s00066_013_0409_z crossref_primary_10_1200_JCO_2016_67_2410 crossref_primary_10_3390_cancers13174493 crossref_primary_10_1007_s11060_017_2647_x crossref_primary_10_3171_2014_6_GKS14708 crossref_primary_10_1007_s11060_015_1733_1 crossref_primary_10_1016_j_bulcan_2019_09_011 crossref_primary_10_1016_j_ijrobp_2017_08_024 crossref_primary_10_1016_S1470_2045_17_30448_5 crossref_primary_10_1016_j_ijrobp_2020_10_034 crossref_primary_10_1186_s13550_020_00739_6 crossref_primary_10_1016_j_wneu_2019_03_041 crossref_primary_10_1016_j_canrad_2024_07_006 crossref_primary_10_1016_j_ctrv_2014_03_005 crossref_primary_10_1016_j_ijrobp_2020_01_051 crossref_primary_10_1007_s00066_018_1387_y crossref_primary_10_1038_s41598_025_10042_w crossref_primary_10_1038_s41571_025_01013_1 crossref_primary_10_1007_s11060_015_2041_5 crossref_primary_10_1186_s12885_019_6307_8 crossref_primary_10_1016_j_wneu_2016_07_038 crossref_primary_10_1186_s13014_020_01558_8 crossref_primary_10_1186_s13058_016_0686_4 crossref_primary_10_3171_2014_7_GKS14972 crossref_primary_10_1007_s00761_013_2528_7 crossref_primary_10_1016_j_canrad_2020_06_019 crossref_primary_10_1016_j_ijrobp_2017_08_014 crossref_primary_10_1002_cncr_32832 crossref_primary_10_1007_s11060_014_1556_5 crossref_primary_10_1016_j_cllc_2025_06_003 crossref_primary_10_1016_j_wneu_2018_09_202 crossref_primary_10_1016_j_ijrobp_2014_10_024 crossref_primary_10_1007_s00066_018_1374_3 crossref_primary_10_1016_j_clon_2017_05_001 crossref_primary_10_1016_j_prro_2022_02_003 crossref_primary_10_3390_cancers13092141 crossref_primary_10_1002_cam4_5928 crossref_primary_10_1227_NEU_0000000000000148 crossref_primary_10_1016_j_ijrobp_2017_09_047 crossref_primary_10_1016_S1470_2045_22_00271_6 crossref_primary_10_1227_NEU_0b013e31827fcd60 crossref_primary_10_3390_cancers13061435 crossref_primary_10_1007_s11910_014_0518_9 crossref_primary_10_1097_CMR_0b013e328352dbef crossref_primary_10_1200_JCO_2013_50_0710 crossref_primary_10_1186_1471_2407_14_931 crossref_primary_10_1016_j_breast_2012_03_003 crossref_primary_10_1016_j_canrad_2020_06_036 crossref_primary_10_1186_s13014_015_0523_4 crossref_primary_10_1177_1758835920953729 crossref_primary_10_1007_s12282_014_0548_9 crossref_primary_10_3389_fneur_2022_806344 crossref_primary_10_1007_s00259_014_2886_4 crossref_primary_10_1016_j_ijrobp_2022_03_020 crossref_primary_10_1093_neuros_nyx346 crossref_primary_10_1016_j_radonc_2018_03_021 crossref_primary_10_2217_fon_2017_0630 crossref_primary_10_3171_2020_3_JNS193419 crossref_primary_10_1186_1748_717X_7_77 crossref_primary_10_1016_j_bulcan_2016_12_003 crossref_primary_10_1093_nop_npz063 crossref_primary_10_1155_2014_417913 crossref_primary_10_2217_lmt_2016_0002 crossref_primary_10_1016_j_thorsurg_2015_09_004 crossref_primary_10_3389_fonc_2018_00380 crossref_primary_10_1186_s13014_019_1337_6 crossref_primary_10_1186_s13014_020_1472_0 crossref_primary_10_1007_s11912_022_01209_z crossref_primary_10_3389_fonc_2018_00385 crossref_primary_10_3389_fonc_2020_591884 crossref_primary_10_1177_107327481302000407 crossref_primary_10_1016_j_wneu_2017_10_159 crossref_primary_10_1159_000358498 crossref_primary_10_1007_s12253_018_0383_y crossref_primary_10_1186_1748_717X_9_143 crossref_primary_10_1016_j_ucl_2020_04_011 crossref_primary_10_1200_JCO_2017_74_0761 crossref_primary_10_3389_fonc_2023_1215426 crossref_primary_10_1007_s10585_024_10326_x crossref_primary_10_1007_s11060_014_1389_2 crossref_primary_10_1371_journal_pone_0253601 crossref_primary_10_1007_s10585_023_10240_8 crossref_primary_10_2217_cns_2016_0025 crossref_primary_10_1007_s11060_016_2242_6 crossref_primary_10_1093_neuonc_nos328 crossref_primary_10_1007_s11060_015_1773_6 crossref_primary_10_1016_j_clineuro_2012_05_018 crossref_primary_10_2217_cns_15_39 crossref_primary_10_3389_fonc_2018_00154 crossref_primary_10_1007_s00066_013_0518_8 crossref_primary_10_1093_jrr_rru092 crossref_primary_10_1016_j_ijrobp_2019_11_022 crossref_primary_10_3390_cancers13194929 crossref_primary_10_1016_j_neucie_2023_07_010 crossref_primary_10_3389_fonc_2022_855182 crossref_primary_10_2217_lmt_2016_0012 crossref_primary_10_1371_journal_pone_0241835 crossref_primary_10_1186_1748_717X_9_155 crossref_primary_10_1007_s10549_022_06595_3 crossref_primary_10_1007_s11060_024_04928_4 crossref_primary_10_1016_j_lungcan_2017_02_012 crossref_primary_10_1515_biol_2022_0559 crossref_primary_10_1016_j_canrad_2020_04_011 crossref_primary_10_1186_s13014_017_0841_9 crossref_primary_10_1038_nrclinonc_2011_58 crossref_primary_10_3389_fonc_2017_00147 crossref_primary_10_1007_s11060_013_1120_8 crossref_primary_10_3171_2015_4_JNS1573 crossref_primary_10_2217_cns_13_66 crossref_primary_10_1007_s11547_017_0735_9 crossref_primary_10_1007_s13566_016_0287_y crossref_primary_10_1093_neuonc_noaa175 crossref_primary_10_1016_j_ijrobp_2013_03_037 crossref_primary_10_1093_neuonc_noac118 crossref_primary_10_1177_1533034614566993 crossref_primary_10_3390_cancers13164030 crossref_primary_10_1016_j_ejphar_2012_11_068 crossref_primary_10_1016_j_ijrobp_2018_04_006 crossref_primary_10_1007_s11060_020_03447_2 crossref_primary_10_1038_s41598_025_93255_3 crossref_primary_10_1093_neuonc_noaa192 crossref_primary_10_1007_s00104_015_0147_0 crossref_primary_10_1016_j_canrad_2017_08_108 crossref_primary_10_1007_s11523_018_0566_1 crossref_primary_10_1200_JCO_2015_60_9503 crossref_primary_10_1017_cjn_2020_250 crossref_primary_10_1007_s13566_012_0006_2 crossref_primary_10_1080_14737175_2016_1184572 crossref_primary_10_1186_s13014_016_0653_3 crossref_primary_10_1016_j_ejmp_2025_104950 crossref_primary_10_1007_s11060_019_03171_6 crossref_primary_10_1007_s12194_022_00684_0 crossref_primary_10_1016_j_bas_2025_105600 crossref_primary_10_1016_j_neuchi_2021_04_001 crossref_primary_10_1007_s10585_019_09986_x crossref_primary_10_1177_1758835920936117 crossref_primary_10_3390_cancers16132466 crossref_primary_10_1007_s00761_013_2561_6 crossref_primary_10_1016_j_radonc_2012_10_014 crossref_primary_10_1097_JTO_0000000000000317 crossref_primary_10_1001_jamanetworkopen_2020_15444 crossref_primary_10_1007_s11060_018_2888_3 crossref_primary_10_1007_s10585_025_10334_5 crossref_primary_10_1002_cnr2_1274 crossref_primary_10_3389_fimmu_2023_1236398 crossref_primary_10_1016_j_radonc_2017_10_010 crossref_primary_10_1016_j_annonc_2021_07_016 crossref_primary_10_1016_j_wneu_2020_09_085 crossref_primary_10_1016_j_wneu_2020_09_082 crossref_primary_10_1177_2058460120938744 crossref_primary_10_25259_SNI_913_2024 crossref_primary_10_3389_fonc_2022_869764 crossref_primary_10_1016_j_clcc_2020_09_002 crossref_primary_10_1186_1748_717X_9_105 crossref_primary_10_1007_s11060_020_03427_6 crossref_primary_10_1016_j_lungcan_2020_06_030 crossref_primary_10_1186_s13014_020_01527_1 crossref_primary_10_3390_cancers15030996 crossref_primary_10_14694_EdBook_AM_2015_35_e8 crossref_primary_10_1016_S1470_2045_14_71106_4 crossref_primary_10_1016_j_canrad_2013_09_002 crossref_primary_10_1016_j_wneu_2012_03_021 crossref_primary_10_1007_s12094_025_03928_8 crossref_primary_10_1007_s13566_013_0093_8 crossref_primary_10_1007_s11060_020_03405_y crossref_primary_10_1016_j_wneu_2017_01_014 crossref_primary_10_1016_j_clon_2020_10_010 crossref_primary_10_1016_j_ctrv_2011_06_008 crossref_primary_10_1007_s00701_023_05826_w crossref_primary_10_2217_bmt_15_27 crossref_primary_10_1016_j_ijrobp_2016_01_037 crossref_primary_10_1007_s10585_017_9865_7 crossref_primary_10_1016_j_ijrobp_2014_12_003 crossref_primary_10_1186_s12885_020_06897_z crossref_primary_10_1007_s00066_021_01872_4 crossref_primary_10_1002_cncr_31352 crossref_primary_10_3389_fonc_2021_732883 crossref_primary_10_1093_annonc_mdy275 crossref_primary_10_1186_1748_717X_9_116 crossref_primary_10_1016_j_cllc_2012_05_002 crossref_primary_10_5812_rro_96969 crossref_primary_10_1007_s11654_017_0014_1 crossref_primary_10_5402_2011_207103 crossref_primary_10_3389_fonc_2025_1554242 crossref_primary_10_1016_S1470_2045_18_30508_4 crossref_primary_10_1093_nop_npz047 crossref_primary_10_2147_CMAR_S279096 crossref_primary_10_3390_cancers14143392 crossref_primary_10_1186_s41747_022_00307_8 crossref_primary_10_3389_fonc_2018_00161 crossref_primary_10_3389_fonc_2020_592796 crossref_primary_10_1016_j_canrad_2021_11_010 crossref_primary_10_1016_j_soc_2013_02_008 crossref_primary_10_1016_j_clineuro_2011_10_042 crossref_primary_10_1227_NEU_0000000000001096 crossref_primary_10_1097_MD_0000000000040334 crossref_primary_10_1007_s00066_024_02202_0 crossref_primary_10_1017_cjn_2020_224 crossref_primary_10_1016_j_ctrv_2024_102860 crossref_primary_10_7861_clinmedicine_14_5_535 crossref_primary_10_1007_s00761_022_01256_y crossref_primary_10_7759_cureus_88553 crossref_primary_10_1007_s00432_012_1344_6 crossref_primary_10_1002_cam4_1726 crossref_primary_10_1016_j_canrad_2016_06_010 crossref_primary_10_1093_neuonc_noad260 crossref_primary_10_1007_s12094_012_0849_4 crossref_primary_10_1200_JCO_2015_60_9305 crossref_primary_10_3171_2018_7_GKS181392 crossref_primary_10_1016_j_canrad_2016_07_041 crossref_primary_10_1002_cncr_30009 crossref_primary_10_1186_s13014_020_01725_x crossref_primary_10_1016_j_ijrobp_2016_01_054 crossref_primary_10_1186_1748_717X_9_132 crossref_primary_10_1007_s11912_017_0599_0 crossref_primary_10_1016_j_lungcan_2019_04_021
ContentType	Journal Article
DBID	CGR CUY CVF ECM EIF NPM 7X8
DOI	10.1200/JCO.2010.30.1655
DatabaseName	Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic
DatabaseTitle	MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic
DatabaseTitleList	MEDLINE MEDLINE - Academic
Database_xml	– sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database
DeliveryMethod	no_fulltext_linktorsrc
Discipline	Medicine Pharmacy, Therapeutics, & Pharmacology
EISSN	1527-7755
ExternalDocumentID	21041710
Genre	Clinical Trial, Phase III Comparative Study Research Support, Non-U.S. Gov't Multicenter Study Randomized Controlled Trial Journal Article Research Support, N.I.H., Extramural
GrantInformation_xml	– fundername: NCI NIH HHS grantid: 2U10 CA11488-25 – fundername: NCI NIH HHS grantid: U10 CA011488 – fundername: NCI NIH HHS grantid: 5U10 CA011488-40
GroupedDBID	--- .55 0R~ 18M 2WC 34G 39C 3O- 4.4 53G 5GY 5RE 8F7 AARDX AAWTL AAYEP AAYOK ABJNI ABOCM ACGFO ACGFS ACGUR ADBBV AEGXH AENEX AFFNX AI. AIAGR ALMA_UNASSIGNED_HOLDINGS BAWUL C45 CGR CS3 CUY CVF DIK EBS ECM EIF EJD F5P F9R FBNNL FD8 GX1 H13 HZ~ IH2 KQ8 L7B LSO MJL N9A NPM O9- OK1 OVD OWW P2P QTD R1G RHI RLZ RUC SJN TEORI TR2 TWZ UDS VH1 VVN WH7 X7M YCJ YFH YQY 7X8 ABBLC
ID	FETCH-LOGICAL-c521t-3e87b47a80f0d7b1c6a548df5b2ed768621ca0d85b69ebe46fc9218a4ca904022
IEDL.DBID	7X8
ISICitedReferencesCount	1538
ISICitedReferencesURI	http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000285965400016&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN	1527-7755
IngestDate	Thu Sep 04 17:06:53 EDT 2025 Thu Apr 03 07:07:31 EDT 2025
IsDoiOpenAccess	false
IsOpenAccess	true
IsPeerReviewed	true
IsScholarly	true
Issue	2
Language	English
LinkModel	DirectLink
MergedId	FETCHMERGED-LOGICAL-c521t-3e87b47a80f0d7b1c6a548df5b2ed768621ca0d85b69ebe46fc9218a4ca904022
Notes	ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 ObjectType-Undefined-3
OpenAccessLink	https://ascopubs.org/doi/pdfdirect/10.1200/JCO.2010.30.1655?role=tab
PMID	21041710
PQID	822903380
PQPubID	23479
ParticipantIDs	proquest_miscellaneous_822903380 pubmed_primary_21041710
PublicationCentury	2000
PublicationDate	2011-01-10
PublicationDateYYYYMMDD	2011-01-10
PublicationDate_xml	– month: 01 year: 2011 text: 2011-01-10 day: 10
PublicationDecade	2010
PublicationPlace	United States
PublicationPlace_xml	– name: United States
PublicationTitle	Journal of clinical oncology
PublicationTitleAlternate	J Clin Oncol
PublicationYear	2011
References	15158627 - Lancet. 2004 May 22;363(9422):1665-72 15127155 - Strahlenther Onkol. 2004 May;180(5):263-7 2405271 - N Engl J Med. 1990 Feb 22;322(8):494-500 1375218 - Int J Radiat Oncol Biol Phys. 1992;23(2):413-8 16757720 - JAMA. 2006 Jun 7;295(21):2483-91 11872278 - Int J Radiat Oncol Biol Phys. 2002 Feb 1;52(2):333-8 18841050 - Curr Opin Oncol. 2008 Nov;20(6):676-84 11323066 - Lancet. 2001 Apr 14;357(9263):1191-4 8901377 - Qual Life Res. 1996 Feb;5(1):139-50 2473409 - Neurosurgery. 1989 Jun;24(6):798-805 10078636 - Int J Radiat Oncol Biol Phys. 1999 Feb 1;43(3):549-58 8700312 - Neurol Med Chir (Tokyo). 1996 Jun;36(6):364-9 3102416 - Int J Radiat Oncol Biol Phys. 1987 Feb;13(2):279-82 17881139 - Int J Radiat Oncol Biol Phys. 2008 Jan 1;70(1):187-93 9817276 - J Clin Oncol. 1998 Nov;16(11):3563-9 3117742 - Int J Radiat Oncol Biol Phys. 1987 Nov;13(11):1611-6 1100130 - Biometrics. 1975 Mar;31(1):103-15 9809728 - JAMA. 1998 Nov 4;280(17):1485-9 6154024 - Int J Radiat Oncol Biol Phys. 1980 Jan;6(1):1-9 8641923 - Int J Radiat Oncol Biol Phys. 1996 Apr 1;35(1):27-35 8433390 - J Natl Cancer Inst. 1993 Mar 3;85(5):365-76 21584645 - Curr Oncol Rep. 2011 Aug;13(4):255-8 21135269 - J Clin Oncol. 2011 Jan 10;29(2):121-4 16237287 - Neurosurgery. 2005 Nov;57(5 Suppl):S33-44; discusssion S1-4 19801201 - Lancet Oncol. 2009 Nov;10(11):1037-44 12062592 - Int J Radiat Oncol Biol Phys. 2002 Jul 1;53(3):519-26 8040016 - Int J Radiat Oncol Biol Phys. 1994 Jul 1;29(4):711-7 15093903 - Int J Radiat Oncol Biol Phys. 2004 May 1;59(1):87-93 7964950 - J Clin Oncol. 1994 Nov;12(11):2340-4 1527610 - J Neurosurg. 1992 Oct;77(4):531-40 10863070 - Int J Radiat Oncol Biol Phys. 2000 Jul 1;47(4):993-9 7713774 - Int J Radiat Oncol Biol Phys. 1995 Mar 30;31(5):1041-2 16956684 - Radiother Oncol. 2006 Sep;80(3):318-22
References_xml	– reference: 21135269 - J Clin Oncol. 2011 Jan 10;29(2):121-4 – reference: 17881139 - Int J Radiat Oncol Biol Phys. 2008 Jan 1;70(1):187-93 – reference: 21584645 - Curr Oncol Rep. 2011 Aug;13(4):255-8 – reference: 1527610 - J Neurosurg. 1992 Oct;77(4):531-40 – reference: 11323066 - Lancet. 2001 Apr 14;357(9263):1191-4 – reference: 6154024 - Int J Radiat Oncol Biol Phys. 1980 Jan;6(1):1-9 – reference: 3102416 - Int J Radiat Oncol Biol Phys. 1987 Feb;13(2):279-82 – reference: 10078636 - Int J Radiat Oncol Biol Phys. 1999 Feb 1;43(3):549-58 – reference: 16956684 - Radiother Oncol. 2006 Sep;80(3):318-22 – reference: 8700312 - Neurol Med Chir (Tokyo). 1996 Jun;36(6):364-9 – reference: 12062592 - Int J Radiat Oncol Biol Phys. 2002 Jul 1;53(3):519-26 – reference: 9817276 - J Clin Oncol. 1998 Nov;16(11):3563-9 – reference: 8901377 - Qual Life Res. 1996 Feb;5(1):139-50 – reference: 2405271 - N Engl J Med. 1990 Feb 22;322(8):494-500 – reference: 9809728 - JAMA. 1998 Nov 4;280(17):1485-9 – reference: 16757720 - JAMA. 2006 Jun 7;295(21):2483-91 – reference: 11872278 - Int J Radiat Oncol Biol Phys. 2002 Feb 1;52(2):333-8 – reference: 3117742 - Int J Radiat Oncol Biol Phys. 1987 Nov;13(11):1611-6 – reference: 8433390 - J Natl Cancer Inst. 1993 Mar 3;85(5):365-76 – reference: 8040016 - Int J Radiat Oncol Biol Phys. 1994 Jul 1;29(4):711-7 – reference: 16237287 - Neurosurgery. 2005 Nov;57(5 Suppl):S33-44; discusssion S1-4 – reference: 2473409 - Neurosurgery. 1989 Jun;24(6):798-805 – reference: 19801201 - Lancet Oncol. 2009 Nov;10(11):1037-44 – reference: 8641923 - Int J Radiat Oncol Biol Phys. 1996 Apr 1;35(1):27-35 – reference: 1100130 - Biometrics. 1975 Mar;31(1):103-15 – reference: 18841050 - Curr Opin Oncol. 2008 Nov;20(6):676-84 – reference: 7713774 - Int J Radiat Oncol Biol Phys. 1995 Mar 30;31(5):1041-2 – reference: 1375218 - Int J Radiat Oncol Biol Phys. 1992;23(2):413-8 – reference: 10863070 - Int J Radiat Oncol Biol Phys. 2000 Jul 1;47(4):993-9 – reference: 7964950 - J Clin Oncol. 1994 Nov;12(11):2340-4 – reference: 15127155 - Strahlenther Onkol. 2004 May;180(5):263-7 – reference: 15093903 - Int J Radiat Oncol Biol Phys. 2004 May 1;59(1):87-93 – reference: 15158627 - Lancet. 2004 May 22;363(9422):1665-72
SSID	ssj0014835
Score	2.594905
Snippet	This European Organisation for Research and Treatment of Cancer phase III trial assesses whether adjuvant whole-brain radiotherapy (WBRT) increases the...
SourceID	proquest pubmed
SourceType	Aggregation Database Index Database
StartPage	134
SubjectTerms	Adult Aged Aged, 80 and over Brain Neoplasms - radiotherapy Brain Neoplasms - secondary Brain Neoplasms - surgery Brain Neoplasms - therapy Disease Progression Disease-Free Survival Female Humans Male Middle Aged Radiosurgery - adverse effects Radiotherapy - adverse effects Radiotherapy, Adjuvant Salvage Therapy Survival Rate
Title	Adjuvant whole-brain radiotherapy versus observation after radiosurgery or surgical resection of one to three cerebral metastases: results of the EORTC 22952-26001 study
URI	https://www.ncbi.nlm.nih.gov/pubmed/21041710 https://www.proquest.com/docview/822903380
Volume	29
WOSCitedRecordID	wos000285965400016&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText
inHoldings	1
isFullTextHit
isPrint
link	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1JSwMxFA5uiBf3feEdpKcGZ1-8iBSLiLZFKvRWMkkGFO1oM1X6k_yXvjcZ7Uk8eBmGIWEG8s3L9_KWj7FT3OW0Uo7kUsWKB55MuEBfiGdRjvuFI1VqW-bfxp1OMhikvTo3x9Rpld82sTLUqpB0Rn5WNSZHf8q5eH3jJBpFwdVaQWOeLfrIZAjU8WAWRAiSSl-ThFuRRIZhHaVEXJzdtLo2rcvHB1EY_s4vq32mvfbPL1xnqzXBhEuLiA02p0ebbPmuDqFvskbPNqueNqE_q70yTWhAb9bGerrFPi_V0wR5dgkfpKHLMxKTgLFQj3XR1hQopWNioMh-jnah0hy3o4ytuIZiDHRLaAAqdqoqKaDIoRhpKAsoEU4apB5TDPsZXnQpkLIabc5p-OS5NDQY3wlX3ft-C0ga3OPU8t6FqjvuNntoX_Vb17wWduCS9BO4r5M4C2KROLmj4syVkUDHSeVh5mkVU82KK4WjkjCLUgRZEOUyRSoiAilSNDqet8MWRviNewyiEP1Lz0fa4omA5mjtZqGb61RLH32pfQbfizXEH4eiIWKki4kZ_izXPtu1Cz58tQ0-hugGBy5Sr4O_Jx-yFXvKTImBR2wxR6Ohj9mSfC8fzfikAiReO727L3wC7Kg
linkProvider	ProQuest
openUrl	ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Adjuvant+whole-brain+radiotherapy+versus+observation+after+radiosurgery+or+surgical+resection+of+one+to+three+cerebral+metastases%3A+results+of+the+EORTC+22952-26001+study&rft.jtitle=Journal+of+clinical+oncology&rft.au=Kocher%2C+Martin&rft.au=Soffietti%2C+Riccardo&rft.au=Abacioglu%2C+Ufuk&rft.au=Vill%C3%A0%2C+Salvador&rft.date=2011-01-10&rft.issn=1527-7755&rft.eissn=1527-7755&rft.volume=29&rft.issue=2&rft.spage=134&rft_id=info:doi/10.1200%2FJCO.2010.30.1655&rft.externalDBID=NO_FULL_TEXT
thumbnail_l	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1527-7755&client=summon
thumbnail_m	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1527-7755&client=summon
thumbnail_s	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1527-7755&client=summon